SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Matrix Pharmaceutical (MATX) -- Ignore unavailable to you. Want to Upgrade?


To: J.F.K. who wrote (188)10/10/1998 8:32:00 PM
From: tnsaf  Read Replies (2) | Respond to of 240
 
Let's add a little life to the thread, eh?
Jason

biz.yahoo.com
Wednesday September 23, 8:08 am Eastern Time
Company Press Release
Matrix Pharmaceutical Licenses
Anticancer Agent Ready for Phase II
Clinical Trials from Hoechst Marion
Roussel

biz.yahoo.com
Thursday October 1, 8:00 am Eastern Time
Company Press Release
Matrix Pharmaceutical Reports
Clinical Results of Intradose Injectable
Gel in Advanced Breast Cancer
47% Tumor Response Rate in Most Troublesome Tumors Reported